ACETYLCYSTEINE

ACETYLCYSTEINE was reported 9624 times

ACETYLCYSTEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HIATUS HERNIA 119 0.5219
1 PRADER-WILLI SYNDROME 8 0.1569
2 SINOBRONCHITIS 23 0.1544
3 MALIGNANT MELANOMA STAGE 0 25 0.1196
4 VASOMOTOR RHINITIS 13 0.0970
5 BODY TINEA 44 0.0786
6 MALIGNANT MELANOMA IN SITU 83 0.0670
7 NIKOLSKY'S SIGN 8 0.0442
8 PNEUMONIA ADENOVIRAL 8 0.0404
9 PROTHROMBIN TIME RATIO DECREASED 25 0.0401
10 ADENOVIRAL HEPATITIS 9 0.0383
11 AUTOINFLAMMATORY DISEASE 8 0.0377
12 COLD URTICARIA 8 0.0364
13 ICHTHYOSIS 9 0.0357
14 BREATH SOUNDS ABNORMAL 140 0.0284
15 INHIBITORY DRUG INTERACTION 44 0.0278
16 BENIGN PROSTATIC HYPERPLASIA 128 0.0248
17 BRONCHIECTASIS 165 0.0245
18 ANION GAP 15 0.0237
19 ALLERGIC SINUSITIS 20 0.0233
20 HEMIANOPIA 23 0.0232
21 CHRONIC HEPATITIS C 9 0.0228
22 EMPYEMA 43 0.0216
23 INFECTION SUSCEPTIBILITY INCREASED 44 0.0201
24 VENOOCCLUSIVE DISEASE 47 0.0188
25 DERMATILLOMANIA 11 0.0185
26 RESPIRATORY TRACT HAEMORRHAGE 11 0.0184
27 SPUTUM PURULENT 12 0.0182
28 SOFT TISSUE SWELLING 10 0.0176
29 GRAFT LOSS 12 0.0166
30 EUSTACHIAN TUBE DYSFUNCTION 9 0.0156
31 DEVICE RELATED SEPSIS 30 0.0149
32 RESPIRATORY TRACT OEDEMA 11 0.0148
33 MUCOSAL EROSION 13 0.0143
34 FULL BLOOD COUNT ABNORMAL 136 0.0128
35 HAEMOPERITONEUM 10 0.0125
36 KLEBSIELLA INFECTION 61 0.0121
37 LYMPHOCELE 8 0.0120
38 OBSTRUCTIVE AIRWAYS DISORDER 125 0.0112
39 ANION GAP INCREASED 15 0.0112
40 SENSE OF OPPRESSION 13 0.0110
41 NECROTISING COLITIS 14 0.0110
42 CHRONIC FATIGUE SYNDROME 15 0.0108
43 PROTHROMBIN TIME SHORTENED 15 0.0107
44 TOXIC EPIDERMAL NECROLYSIS 160 0.0105
45 HYPERCHOLESTEROLAEMIA 100 0.0103
46 ANAPHYLACTOID REACTION 42 0.0102
47 HEPATITIS VIRAL 8 0.0100
48 ABDOMINAL ABSCESS 43 0.0097
49 SPUTUM INCREASED 21 0.0097
50 ACUTE PRERENAL FAILURE 11 0.0095
51 ALCOHOL WITHDRAWAL SYNDROME 8 0.0092
52 ORAL MUCOSAL ERUPTION 14 0.0091
53 MICTURITION URGENCY 102 0.0089
54 ENTEROCOCCAL INFECTION 43 0.0089
55 STAPHYLOCOCCAL BACTERAEMIA 38 0.0087
56 HYPERPARATHYROIDISM 18 0.0087
57 BRONCHIAL SECRETION RETENTION 11 0.0086
58 HYPERCAPNIA 26 0.0086
59 THROMBOTIC THROMBOCYTOPENIC PURPURA 29 0.0082
60 ANALGESIC DRUG LEVEL INCREASED 13 0.0081
61 BEZOAR 11 0.0080
62 GLUCOSE TOLERANCE IMPAIRED 46 0.0078
63 VASCULAR DEVICE INFECTION 35 0.0077
64 STAPHYLOCOCCAL SEPSIS 38 0.0077
65 IDIOPATHIC PULMONARY FIBROSIS 29 0.0073
66 BRAIN DEATH 22 0.0071
67 POST PROCEDURAL HAEMATOMA 12 0.0071
68 CELL DEATH 14 0.0071
69 LYMPHOCYTOSIS 15 0.0070
70 ACUTE HEPATIC FAILURE 95 0.0069
71 RESTRICTIVE PULMONARY DISEASE 8 0.0068
72 HEPATITIS FULMINANT 20 0.0067
73 HYPERTHERMIA MALIGNANT 10 0.0067
74 RALES 37 0.0064
75 BRAIN HERNIATION 19 0.0064
76 HYPERLACTACIDAEMIA 17 0.0063
77 HYPOPROTEINAEMIA 12 0.0063
78 TRACHEOSTOMY 9 0.0063
79 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 8 0.0063
80 OBSTRUCTIVE SLEEP APNOEA SYNDROME 9 0.0062
81 STEVENS-JOHNSON SYNDROME 136 0.0061
82 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 33 0.0061
83 BRAIN OEDEMA 76 0.0060
84 PURPURA 53 0.0060
85 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 311 0.0060
86 ERYSIPELAS 28 0.0056
87 VASOPLEGIA SYNDROME 9 0.0055
88 GOITRE 22 0.0054
89 DEAFNESS BILATERAL 9 0.0053
90 PRODUCTIVE COUGH 251 0.0053
91 TONGUE OEDEMA 20 0.0052
92 CATHETER SITE HAEMORRHAGE 13 0.0052
93 HYPERURICAEMIA 21 0.0051
94 AUTOIMMUNE THYROIDITIS 19 0.0050
95 HYPERLIPIDAEMIA 60 0.0050
96 PERSONALITY DISORDER 13 0.0050
97 CARDIOVASCULAR INSUFFICIENCY 8 0.0049
98 NASAL POLYPS 24 0.0049
99 LOBAR PNEUMONIA 9 0.0049
100 ATRIAL TACHYCARDIA 10 0.0048
101 LEUKOCYTOSIS 86 0.0047
102 HEPATIC ENCEPHALOPATHY 44 0.0047
103 JOINT INJURY 100 0.0047
104 ATYPICAL PNEUMONIA 14 0.0047
105 VENTRICULAR DYSFUNCTION 12 0.0046
106 CYSTIC FIBROSIS 25 0.0045
107 HEPATIC NECROSIS 17 0.0045
108 DYSPNOEA EXERTIONAL 168 0.0045
109 TACHYARRHYTHMIA 11 0.0044
110 HYPOALBUMINAEMIA 34 0.0044
111 COAGULOPATHY 72 0.0043
112 SLEEP DEFICIT 9 0.0043
113 HEPATITIS TOXIC 11 0.0042
114 IMPAIRED QUALITY OF LIFE 60 0.0042
115 HEPATOTOXICITY 92 0.0041
116 NASAL SEPTUM DEVIATION 8 0.0041
117 TRANSIENT ISCHAEMIC ATTACK 138 0.0041
118 WOUND COMPLICATION 14 0.0041
119 CORONARY ARTERY DISEASE 122 0.0040
120 RENAL COLIC 9 0.0040
121 PULMONARY HAEMORRHAGE 31 0.0040
122 EYELID PAIN 8 0.0039
123 ENDOTRACHEAL INTUBATION 11 0.0039
124 AORTIC ARTERIOSCLEROSIS 10 0.0039
125 HAEMOLYTIC URAEMIC SYNDROME 9 0.0039
126 ACUTE RESPIRATORY FAILURE 74 0.0038
127 ORTHOPNOEA 12 0.0038
128 POOR QUALITY SLEEP 81 0.0038
129 ANAEMIA MACROCYTIC 8 0.0037
130 AREFLEXIA 10 0.0037
131 CYANOSIS 58 0.0037
132 BRONCHITIS CHRONIC 9 0.0037
133 NEPHROPATHY TOXIC 41 0.0036
134 BRONCHOSPASM 52 0.0036
135 METABOLIC ACIDOSIS 116 0.0036
136 RHINOVIRUS INFECTION 14 0.0036
137 POTENTIATING DRUG INTERACTION 12 0.0036
138 DIASTOLIC DYSFUNCTION 11 0.0036
139 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18 0.0036
140 CHRONIC GASTRITIS 8 0.0035
141 LIP OEDEMA 15 0.0035
142 HEPATITIS ACUTE 23 0.0035
143 TACHYPNOEA 48 0.0035
144 BACTERAEMIA 41 0.0035
145 DERMATITIS BULLOUS 25 0.0035
146 PULMONARY FUNCTION TEST DECREASED 15 0.0034
147 HYPOKALAEMIA 157 0.0034
148 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 9 0.0034
149 OLIGURIA 21 0.0034
150 ORAL HERPES 66 0.0034
151 WHEEZING 198 0.0033
152 CLOSTRIDIUM DIFFICILE COLITIS 35 0.0033
153 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 20 0.0033
154 ACUTE RESPIRATORY DISTRESS SYNDROME 58 0.0033
155 AZOTAEMIA 13 0.0033
156 NEPHROGENIC ANAEMIA 15 0.0032
157 INTRACRANIAL PRESSURE INCREASED 18 0.0032
158 BLOOD LACTIC ACID INCREASED 17 0.0032
159 BRONCHOPNEUMONIA 11 0.0032
160 TONGUE DISCOLOURATION 14 0.0032
161 CANDIDA INFECTION 54 0.0032
162 HYPERPARATHYROIDISM SECONDARY 8 0.0032
163 HYPERTRANSAMINASAEMIA 22 0.0032
164 LEG AMPUTATION 13 0.0032
165 ACIDOSIS 24 0.0031
166 RESPIRATORY FAILURE 229 0.0031
167 LIP PAIN 9 0.0031
168 INCREASED BRONCHIAL SECRETION 8 0.0031
169 HYPOPHOSPHATAEMIA 23 0.0031
170 STRIDOR 9 0.0031
171 LUNG OPACITY 8 0.0030
172 RESPIRATORY TRACT INFECTION 77 0.0030
173 NEUROLEPTIC MALIGNANT SYNDROME 35 0.0029
174 OBESITY 47 0.0029
175 PNEUMONIA BACTERIAL 27 0.0029
176 RESPIRATORY DEPRESSION 36 0.0029
177 CHRONIC SINUSITIS 11 0.0029
178 PSEUDOMONAS INFECTION 25 0.0029
179 CERVICAL VERTEBRAL FRACTURE 10 0.0029
180 SEPTIC SHOCK 126 0.0029
181 ERYTHEMA MULTIFORME 27 0.0029
182 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82 0.0029
183 RASH MORBILLIFORM 8 0.0029
184 HYPOXIA 101 0.0029
185 BLOOD UREA INCREASED 48 0.0029
186 NEUTROPHIL COUNT ABNORMAL 8 0.0028
187 PNEUMONIA VIRAL 9 0.0028
188 HYPERNATRAEMIA 14 0.0028
189 GASTROINTESTINAL MOTILITY DISORDER 15 0.0028
190 STUPOR 9 0.0028
191 HYPOVENTILATION 9 0.0028
192 HYPOMAGNESAEMIA 38 0.0027
193 DEVICE RELATED INFECTION 42 0.0027
194 ASPHYXIA 22 0.0027
195 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
196 CREPITATIONS 8 0.0027
197 ATRIOVENTRICULAR BLOCK SECOND DEGREE 8 0.0026
198 HYPERVOLAEMIA 13 0.0026
199 HERPES SIMPLEX 17 0.0026
200 DYSAESTHESIA 8 0.0026
201 PNEUMONIA ASPIRATION 65 0.0026
202 HAEMOLYSIS 20 0.0026
203 AUTOIMMUNE HEPATITIS 18 0.0026
204 ATELECTASIS 25 0.0026
205 NECROTISING FASCIITIS 9 0.0026
206 RESPIRATORY RATE DECREASED 8 0.0025
207 MULTI-ORGAN FAILURE 44 0.0025
208 RESPIRATORY ACIDOSIS 10 0.0025
209 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 13 0.0025
210 FIBRIN D DIMER INCREASED 9 0.0025
211 SPINAL OSTEOARTHRITIS 22 0.0025
212 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
213 HAEMODYNAMIC INSTABILITY 19 0.0025
214 LUNG INFILTRATION 22 0.0025
215 IMPAIRED WORK ABILITY 53 0.0025
216 HYPOTHERMIA 25 0.0025
217 CUTANEOUS VASCULITIS 9 0.0025
218 ILEUS PARALYTIC 11 0.0025
219 VENTRICULAR ARRHYTHMIA 9 0.0025
220 ENCEPHALITIS 17 0.0025
221 PULMONARY FIBROSIS 47 0.0024
222 CHOLESTASIS 47 0.0024
223 ENCEPHALOPATHY 60 0.0024
224 POLYURIA 20 0.0024
225 INFUSION SITE HAEMORRHAGE 8 0.0024
226 SPUTUM DISCOLOURED 23 0.0024
227 HEPATIC FAILURE 73 0.0024
228 CYTOLYTIC HEPATITIS 8 0.0024
229 BLOOD LACTATE DEHYDROGENASE INCREASED 38 0.0024
230 BUNDLE BRANCH BLOCK RIGHT 11 0.0024
231 RESPIRATORY DISTRESS 66 0.0024
232 UROSEPSIS 22 0.0024
233 CLOSTRIDIUM DIFFICILE INFECTION 52 0.0024
234 DYSPHORIA 12 0.0024
235 PATHOLOGICAL FRACTURE 12 0.0024
236 INTESTINAL ISCHAEMIA 13 0.0024
237 BUNDLE BRANCH BLOCK LEFT 10 0.0024
238 RHINITIS 19 0.0024
239 ASPARTATE AMINOTRANSFERASE INCREASED 125 0.0024
240 FLANK PAIN 22 0.0023
241 TRANSAMINASES INCREASED 52 0.0023
242 ASTHMA 264 0.0023
243 WOUND SECRETION 9 0.0023
244 AORTIC STENOSIS 8 0.0023
245 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 126 0.0023
246 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
247 PNEUMONIA FUNGAL 9 0.0023
248 PNEUMONITIS 62 0.0023
249 SERUM FERRITIN INCREASED 12 0.0023
250 HAEMOPTYSIS 63 0.0023
251 OBSTRUCTION 9 0.0023
252 VENTRICULAR FIBRILLATION 25 0.0022
253 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108 0.0022
254 HEPATOMEGALY 22 0.0022
255 HEPARIN-INDUCED THROMBOCYTOPENIA 11 0.0022
256 SHOCK HAEMORRHAGIC 18 0.0022
257 CONJUNCTIVITIS 41 0.0022
258 LIVER TRANSPLANT 8 0.0022
259 DERMATITIS EXFOLIATIVE 11 0.0022
260 BRONCHOPULMONARY ASPERGILLOSIS 17 0.0022
261 CORONARY ARTERY STENOSIS 11 0.0022
262 ODYNOPHAGIA 13 0.0022
263 ISCHAEMIA 10 0.0022
264 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
265 PROTHROMBIN TIME PROLONGED 13 0.0022
266 POLYNEUROPATHY 26 0.0022
267 DRUG-INDUCED LIVER INJURY 68 0.0022
268 TACHYCARDIA 192 0.0022
269 EOSINOPHIL COUNT INCREASED 18 0.0022
270 HEPATITIS CHOLESTATIC 13 0.0022
271 RASH MACULO-PAPULAR 48 0.0022
272 SECRETION DISCHARGE 27 0.0022
273 PETIT MAL EPILEPSY 11 0.0022
274 ALANINE AMINOTRANSFERASE INCREASED 132 0.0021
275 HAEMODIALYSIS 18 0.0021
276 BLOOD CREATININE INCREASED 139 0.0021
277 SKIN ABRASION 10 0.0021
278 SKIN DISORDER 70 0.0021
279 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
280 EMPHYSEMA 21 0.0021
281 FAECAL INCONTINENCE 10 0.0021
282 FACE OEDEMA 35 0.0021
283 HYPERVENTILATION 12 0.0021
284 UPPER-AIRWAY COUGH SYNDROME 17 0.0021
285 NEUTROPHIL COUNT INCREASED 21 0.0020
286 PSYCHIATRIC SYMPTOM 15 0.0020
287 CATHETERISATION CARDIAC 9 0.0020
288 HYPERCALCAEMIA 25 0.0020
289 FEBRILE NEUTROPENIA 134 0.0020
290 PNEUMONIA 651 0.0020
291 JAUNDICE 54 0.0020
292 SYMPTOM RECURRENCE 12 0.0020
293 COMA 95 0.0020
294 MUSCLE HAEMORRHAGE 8 0.0020
295 URINE ABNORMALITY 9 0.0020
296 ABDOMINAL HERNIA 9 0.0020
297 PULMONARY CONGESTION 26 0.0020
298 SEPSIS 219 0.0020
299 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
300 HYPOCALCAEMIA 37 0.0020
301 INCREASED UPPER AIRWAY SECRETION 10 0.0019
302 CEREBRAL ISCHAEMIA 10 0.0019
303 GAMMA-GLUTAMYLTRANSFERASE INCREASED 43 0.0019
304 LUNG INFECTION 30 0.0019
305 IMMUNOSUPPRESSION 17 0.0019
306 LUNG DISORDER 94 0.0019
307 ELECTROCARDIOGRAM ABNORMAL 15 0.0019
308 INFUSION SITE SWELLING 12 0.0019
309 BLOOD URIC ACID INCREASED 11 0.0019
310 DELIRIUM 66 0.0019
311 SINUS TACHYCARDIA 27 0.0019
312 PNEUMOTHORAX 30 0.0019
313 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 32 0.0019
314 HYPOVOLAEMIA 11 0.0019
315 NON-SMALL CELL LUNG CANCER 9 0.0019
316 RESPIRATORY DISORDER 56 0.0019
317 LYMPHOCYTE COUNT DECREASED 33 0.0019
318 RENAL FAILURE ACUTE 79 0.0019
319 PYELONEPHRITIS 16 0.0018
320 MYOCARDITIS 21 0.0018
321 FAECALOMA 10 0.0018
322 VENTRICULAR TACHYCARDIA 30 0.0018
323 ORGANISING PNEUMONIA 9 0.0018
324 INFLAMMATORY MARKER INCREASED 9 0.0018
325 OXYGEN SATURATION DECREASED 102 0.0018
326 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 129 0.0018
327 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
328 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
329 HYPONATRAEMIA 101 0.0018
330 GENERAL PHYSICAL HEALTH DETERIORATION 207 0.0018
331 INTERNATIONAL NORMALISED RATIO INCREASED 51 0.0018
332 SENSATION OF FOREIGN BODY 15 0.0018
333 DRUG INTERACTION 281 0.0018
334 AMMONIA INCREASED 9 0.0018
335 C-REACTIVE PROTEIN INCREASED 64 0.0018
336 DRUG LEVEL INCREASED 29 0.0018
337 TRANSPLANT REJECTION 14 0.0017
338 PERIPHERAL VASCULAR DISORDER 9 0.0017
339 LUMBAR VERTEBRAL FRACTURE 8 0.0017
340 VARICOSE VEIN 9 0.0017
341 PANCYTOPENIA 97 0.0017
342 ASPIRATION 19 0.0017
343 PLEURAL EFFUSION 105 0.0017
344 BONE DENSITY DECREASED 54 0.0017
345 BACTERIAL INFECTION 32 0.0017
346 RIGHT VENTRICULAR FAILURE 12 0.0017
347 MALNUTRITION 19 0.0017
348 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 15 0.0017
349 ACUTE CORONARY SYNDROME 14 0.0017
350 TENDON DISORDER 11 0.0017
351 PLEURISY 10 0.0017
352 GASTROOESOPHAGEAL REFLUX DISEASE 135 0.0017
353 HYPOVOLAEMIC SHOCK 8 0.0017
354 KIDNEY TRANSPLANT REJECTION 8 0.0017
355 HEPATIC STEATOSIS 31 0.0017
356 ACUTE MYOCARDIAL INFARCTION 49 0.0017
357 HAEMATOMA 43 0.0017
358 NOCTURIA 20 0.0016
359 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
360 POST-TRAUMATIC STRESS DISORDER 11 0.0016
361 LIVER INJURY 40 0.0016
362 ATRIAL FLUTTER 13 0.0016
363 BLOOD BILIRUBIN INCREASED 44 0.0016
364 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
365 CELLULITIS 82 0.0016
366 CARDIOMEGALY 20 0.0016
367 GRAND MAL CONVULSION 15 0.0016
368 LARYNGEAL OEDEMA 10 0.0016
369 BLOOD MAGNESIUM DECREASED 14 0.0016
370 SKIN HAEMORRHAGE 24 0.0016
371 THROMBOCYTOPENIA 180 0.0016
372 COVID-19 PNEUMONIA 19 0.0016
373 ACUTE KIDNEY INJURY 246 0.0016
374 HYPERKALAEMIA 56 0.0016
375 REBOUND EFFECT 18 0.0016
376 TOXICITY TO VARIOUS AGENTS 267 0.0016
377 INTENTIONAL OVERDOSE 101 0.0016
378 NEUROLOGICAL SYMPTOM 9 0.0016
379 SHOCK 36 0.0016
380 HERPES VIRUS INFECTION 9 0.0016
381 GASTROINTESTINAL INFECTION 14 0.0016
382 RENAL FAILURE CHRONIC 12 0.0016
383 RENAL IMPAIRMENT 131 0.0016
384 DUODENAL ULCER 11 0.0016
385 ATRIOVENTRICULAR BLOCK 12 0.0016
386 ANAPHYLACTIC SHOCK 40 0.0015
387 NEUTROPHIL COUNT DECREASED 63 0.0015
388 CATARACT 92 0.0015
389 MALABSORPTION 8 0.0015
390 PHARYNGITIS 19 0.0015
391 MULTIPLE ALLERGIES 12 0.0015
392 TORSADE DE POINTES 12 0.0015
393 PULMONARY OEDEMA 68 0.0015
394 DEPRESSED LEVEL OF CONSCIOUSNESS 60 0.0015
395 CEREBRAL INFARCTION 37 0.0015
396 MEDICATION ERROR 84 0.0015
397 ANURIA 13 0.0015
398 HYPOTENSION 303 0.0015
399 RASH PUSTULAR 11 0.0015
400 APPETITE DISORDER 10 0.0015
401 STATUS EPILEPTICUS 17 0.0015
402 APHONIA 21 0.0015
403 PYREXIA 520 0.0015
404 HYPERTENSION 318 0.0015
405 MUSCLE ATROPHY 19 0.0015
406 GANGRENE 9 0.0015
407 ORTHOSTATIC HYPOTENSION 26 0.0015
408 UPPER GASTROINTESTINAL HAEMORRHAGE 25 0.0015
409 MYDRIASIS 19 0.0015
410 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
411 ATRIAL FIBRILLATION 143 0.0015
412 RESPIRATORY RATE INCREASED 13 0.0015
413 ELECTROLYTE IMBALANCE 17 0.0015
414 ECCHYMOSIS 10 0.0015
415 ONYCHOCLASIS 10 0.0015
416 AGRANULOCYTOSIS 27 0.0015
417 JOINT EFFUSION 10 0.0014
418 UPPER RESPIRATORY TRACT INFECTION 67 0.0014
419 HYPERBILIRUBINAEMIA 15 0.0014
420 EMBOLISM 12 0.0014
421 EOSINOPHILIA 25 0.0014
422 SKIN LESION 39 0.0014
423 DYSPNOEA 800 0.0014
424 APNOEA 11 0.0014
425 CARDIAC FAILURE 113 0.0014
426 ENTERITIS 9 0.0014
427 CARDIAC ARREST 116 0.0014
428 OEDEMA PERIPHERAL 171 0.0014
429 BRAIN INJURY 14 0.0014
430 BRADYCARDIA 74 0.0014
431 PULMONARY HYPERTENSION 29 0.0014
432 EXERCISE TOLERANCE DECREASED 8 0.0014
433 ENTEROCOLITIS 8 0.0014
434 BRONCHITIS 102 0.0014
435 GENERALISED OEDEMA 17 0.0014
436 POISONING DELIBERATE 13 0.0014
437 HEPATITIS 35 0.0014
438 GROIN PAIN 12 0.0014
439 TUMOUR LYSIS SYNDROME 12 0.0014
440 CIRCULATORY COLLAPSE 23 0.0013
441 BLOOD IRON DECREASED 16 0.0013
442 ABNORMAL FAECES 11 0.0013
443 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23 0.0013
444 HICCUPS 11 0.0013
445 HAEMOLYTIC ANAEMIA 12 0.0013
446 ANAEMIA 255 0.0013
447 AUTOIMMUNE DISORDER 13 0.0013
448 CHROMATURIA 30 0.0013
449 ANGINA PECTORIS 38 0.0013
450 RENAL TUBULAR NECROSIS 13 0.0013
451 MITRAL VALVE INCOMPETENCE 15 0.0013
452 CARDIOGENIC SHOCK 19 0.0013
453 AORTIC ANEURYSM 10 0.0013
454 ANAPHYLACTIC REACTION 72 0.0013
455 HAIR GROWTH ABNORMAL 9 0.0013
456 SALIVARY HYPERSECRETION 13 0.0013
457 SEDATION 34 0.0013
458 BLOOD POTASSIUM DECREASED 39 0.0013
459 RHABDOMYOLYSIS 54 0.0013
460 CYST 16 0.0013
461 ILEUS 16 0.0013
462 ARTERIOSCLEROSIS 12 0.0013
463 MUSCLE STRAIN 11 0.0013
464 PHOTOPSIA 8 0.0013
465 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
466 NEUTROPENIC SEPSIS 9 0.0013
467 PRODUCT PRESCRIBING ERROR 30 0.0013
468 TRICUSPID VALVE INCOMPETENCE 10 0.0013
469 PERICARDIAL EFFUSION 29 0.0013
470 GRAFT VERSUS HOST DISEASE 9 0.0013
471 RENAL FAILURE 166 0.0012
472 PETECHIAE 13 0.0012
473 VISUAL FIELD DEFECT 9 0.0012
474 HYPERTHYROIDISM 18 0.0012
475 LIVER FUNCTION TEST ABNORMAL 36 0.0012
476 ADRENAL INSUFFICIENCY 15 0.0012
477 HERPES ZOSTER 71 0.0012
478 ANGINA UNSTABLE 8 0.0012
479 VITAMIN D DEFICIENCY 12 0.0012
480 ANGIOEDEMA 54 0.0012
481 OROPHARYNGEAL DISCOMFORT 11 0.0012
482 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
483 GASTRIC HAEMORRHAGE 14 0.0012
484 ESCHERICHIA INFECTION 10 0.0012
485 BRAIN FOG 19 0.0012
486 LACTIC ACIDOSIS 39 0.0012
487 AGEUSIA 30 0.0012
488 CARDIAC FAILURE ACUTE 8 0.0012
489 SKIN LACERATION 13 0.0012
490 DERMATITIS ALLERGIC 15 0.0012
491 TOXIC SKIN ERUPTION 12 0.0012
492 OSTEOPOROSIS 49 0.0012
493 OESOPHAGITIS 13 0.0012
494 TROPONIN INCREASED 9 0.0012
495 INTERSTITIAL LUNG DISEASE 57 0.0012
496 CHOLECYSTITIS 14 0.0012
497 BLOOD SODIUM DECREASED 22 0.0012
498 FOOD ALLERGY 9 0.0012
499 INFUSION SITE PAIN 15 0.0012
500 RHINORRHOEA 75 0.0012
501 LYMPHOEDEMA 8 0.0012
502 COUGH 323 0.0012
503 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
504 URINARY INCONTINENCE 34 0.0011
505 POST PROCEDURAL COMPLICATION 22 0.0011
506 SEROTONIN SYNDROME 22 0.0011
507 PLATELET COUNT DECREASED 122 0.0011
508 URINE OUTPUT DECREASED 10 0.0011
509 CYTOMEGALOVIRUS INFECTION 19 0.0011
510 MYOCARDIAL ISCHAEMIA 13 0.0011
511 BLOOD TEST ABNORMAL 16 0.0011
512 SUICIDE ATTEMPT 69 0.0011
513 UNRESPONSIVE TO STIMULI 29 0.0011
514 DISORIENTATION 44 0.0011
515 THYROID DISORDER 17 0.0011
516 DRUG TOXICITY 15 0.0011
517 FLUID OVERLOAD 16 0.0011
518 HEPATIC FUNCTION ABNORMAL 41 0.0011
519 HYPERGLYCAEMIA 40 0.0011
520 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
521 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
522 DIVERTICULITIS 30 0.0011
523 HIATUS HERNIA 14 0.0011
524 INFECTION 156 0.0011
525 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
526 HEAD INJURY 34 0.0011
527 HYPOGLYCAEMIA 52 0.0011
528 SKIN INFECTION 12 0.0011
529 INFUSION SITE ERYTHEMA 9 0.0011
530 CHEST DISCOMFORT 109 0.0011
531 GASTRITIS 28 0.0011
532 CARDIOVASCULAR DISORDER 27 0.0011
533 ORAL CANDIDIASIS 14 0.0011
534 ALTERED STATE OF CONSCIOUSNESS 23 0.0011
535 PAROSMIA 8 0.0011
536 LEUKOPENIA 53 0.0011
537 FACIAL PARALYSIS 9 0.0011
538 PRESCRIBED UNDERDOSE 21 0.0011
539 BLISTER 59 0.0010
540 LIPASE INCREASED 8 0.0010
541 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
542 PULMONARY EMBOLISM 99 0.0010
543 END STAGE RENAL DISEASE 19 0.0010
544 JOINT DISLOCATION 11 0.0010
545 STOMATITIS 63 0.0010
546 RESTLESSNESS 38 0.0010
547 CEREBRAL HAEMORRHAGE 37 0.0010
548 BODY TEMPERATURE INCREASED 21 0.0010
549 HAEMATURIA 35 0.0010
550 RIB FRACTURE 21 0.0010
551 ARRHYTHMIA 48 0.0010
552 DIABETES MELLITUS 77 0.0010
553 RESPIRATORY TRACT CONGESTION 16 0.0010
554 MYOCLONUS 12 0.0010
555 HAEMARTHROSIS 9 0.0010
556 MELAENA 22 0.0010
557 OEDEMA 54 0.0010
558 HALLUCINATION, VISUAL 21 0.0010
559 JOINT STIFFNESS 26 0.0010
560 CONDITION AGGRAVATED 301 0.0010
561 LYMPHOPENIA 14 0.0010
562 ECONOMIC PROBLEM 15 0.0010
563 DIALYSIS 14 0.0010
564 BLOOD POTASSIUM INCREASED 16 0.0010
565 SUBARACHNOID HAEMORRHAGE 10 0.0010
566 DECUBITUS ULCER 8 0.0010
567 INSURANCE ISSUE 15 0.0010
568 CARDIO-RESPIRATORY ARREST 41 0.0010
569 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
570 TENDON RUPTURE 12 0.0010
571 STAPHYLOCOCCAL INFECTION 32 0.0010
572 OVERDOSE 209 0.0010
573 AGITATION 71 0.0010
574 VENTRICULAR EXTRASYSTOLES 10 0.0010
575 GASTROENTERITIS 14 0.0010
576 SINUSITIS 98 0.0010
577 INCORRECT ROUTE OF DRUG ADMINISTRATION 34 0.0010
578 MENTAL IMPAIRMENT 23 0.0009
579 CARDIOMYOPATHY 14 0.0009
580 GASTRIC ULCER 18 0.0009
581 TOOTH DISORDER 21 0.0009
582 IMPAIRED HEALING 31 0.0009
583 MYELOSUPPRESSION 34 0.0009
584 SLEEP APNOEA SYNDROME 18 0.0009
585 HEPATIC CYTOLYSIS 12 0.0009
586 EATING DISORDER 20 0.0009
587 IMMUNODEFICIENCY 14 0.0009
588 HYPERHIDROSIS 120 0.0009
589 SINUS BRADYCARDIA 9 0.0009
590 ACCIDENTAL OVERDOSE 34 0.0009
591 THROMBOTIC MICROANGIOPATHY 9 0.0009
592 OSTEOPENIA 14 0.0009
593 LIMB INJURY 25 0.0009
594 PHARYNGEAL SWELLING 9 0.0009
595 ASCITES 27 0.0009
596 BLOOD PRESSURE DECREASED 61 0.0009
597 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
598 MUCOSAL INFLAMMATION 24 0.0009
599 WHITE BLOOD CELL COUNT INCREASED 35 0.0009
600 LIGAMENT SPRAIN 9 0.0009
601 DECREASED APPETITE 210 0.0009
602 DENTAL CARIES 10 0.0009
603 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
604 GASTROINTESTINAL HAEMORRHAGE 75 0.0009
605 FACIAL PAIN 8 0.0009
606 TASTE DISORDER 18 0.0009
607 DEAFNESS 23 0.0009
608 POISONING 11 0.0009
609 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
610 IRON DEFICIENCY ANAEMIA 8 0.0009
611 TENDERNESS 9 0.0009
612 EYELID OEDEMA 10 0.0009
613 POST PROCEDURAL HAEMORRHAGE 10 0.0009
614 HAEMATOCRIT DECREASED 17 0.0009
615 NEPHROPATHY 8 0.0009
616 ROTATOR CUFF SYNDROME 11 0.0009
617 FEAR 23 0.0009
618 COVID-19 150 0.0009
619 MOUTH ULCERATION 18 0.0009
620 LOSS OF CONSCIOUSNESS 109 0.0008
621 MENTAL DISORDER 37 0.0008
622 SLEEP DISORDER 60 0.0008
623 SEASONAL ALLERGY 12 0.0008
624 HAEMOGLOBIN DECREASED 87 0.0008
625 SNEEZING 19 0.0008
626 NEUTROPENIA 115 0.0008
627 SEIZURE 97 0.0008
628 URINARY RETENTION 28 0.0008
629 URINARY TRACT INFECTION 143 0.0008
630 HEART RATE INCREASED 83 0.0008
631 EJECTION FRACTION DECREASED 13 0.0008
632 LOWER LIMB FRACTURE 16 0.0008
633 CONTUSION 80 0.0008
634 LACRIMATION INCREASED 25 0.0008
635 BURSITIS 10 0.0008
636 FIBROMYALGIA 20 0.0008
637 NEURALGIA 20 0.0008
638 HAEMORRHOIDS 16 0.0008
639 NASAL CONGESTION 48 0.0008
640 CONSTIPATION 177 0.0008
641 FLATULENCE 46 0.0008
642 SINUS DISORDER 16 0.0008
643 IMPAIRED GASTRIC EMPTYING 11 0.0008
644 PULMONARY MASS 12 0.0008
645 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
646 NEUROTOXICITY 14 0.0008
647 HEPATIC CIRRHOSIS 15 0.0008
648 PHOTOPHOBIA 15 0.0008
649 ABDOMINAL PAIN LOWER 20 0.0008
650 DYSPHAGIA 75 0.0008
651 EAR INFECTION 21 0.0008
652 ECZEMA 41 0.0008
653 SKIN REACTION 11 0.0008
654 GOUT 14 0.0008
655 METASTASES TO LUNG 9 0.0008
656 OFF LABEL USE 680 0.0008
657 ANOREXIA 10 0.0008
658 FEMUR FRACTURE 24 0.0008
659 RENAL INJURY 23 0.0008
660 SKIN ULCER 20 0.0008
661 VASCULITIS 9 0.0008
662 PERITONITIS 16 0.0008
663 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
664 PARAESTHESIA ORAL 11 0.0008
665 SCAR 13 0.0008
666 CHILLS 89 0.0008
667 FLUSHING 77 0.0008
668 INFLAMMATION 39 0.0008
669 OSTEOARTHRITIS 32 0.0008
670 BLOOD PRESSURE ABNORMAL 15 0.0008
671 HYPOTHYROIDISM 24 0.0008
672 INTENTIONAL PRODUCT MISUSE 65 0.0007
673 DYSPEPSIA 73 0.0007
674 INTENTIONAL DOSE OMISSION 21 0.0007
675 SWOLLEN TONGUE 23 0.0007
676 LYMPHADENOPATHY 26 0.0007
677 AKATHISIA 10 0.0007
678 METASTASES TO BONE 12 0.0007
679 PREMATURE BABY 22 0.0007
680 VOMITING 342 0.0007
681 ABDOMINAL PAIN 169 0.0007
682 BLOOD COUNT ABNORMAL 11 0.0007
683 INFUSION RELATED REACTION 48 0.0007
684 DISTURBANCE IN ATTENTION 39 0.0007
685 EPISTAXIS 54 0.0007
686 FOOT DEFORMITY 8 0.0007
687 EAR PAIN 14 0.0007
688 ERYTHEMA 148 0.0007
689 EPILEPSY 22 0.0007
690 ORAL DISCOMFORT 10 0.0007
691 INFLUENZA 80 0.0007
692 COORDINATION ABNORMAL 10 0.0007
693 DERMATITIS 15 0.0007
694 INTESTINAL PERFORATION 8 0.0007
695 RENAL DISORDER 33 0.0007
696 ABDOMINAL DISTENSION 73 0.0007
697 TREMOR 116 0.0007
698 LIVER FUNCTION TEST INCREASED 15 0.0007
699 HYPERSOMNIA 20 0.0007
700 CHRONIC KIDNEY DISEASE 53 0.0007
701 TINNITUS 32 0.0007
702 MUSCULAR WEAKNESS 79 0.0007
703 VIRAL INFECTION 23 0.0007
704 ANOSMIA 10 0.0007
705 PREMATURE DELIVERY 11 0.0007
706 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
707 SCIATICA 11 0.0007
708 PANIC ATTACK 25 0.0007
709 SENSORY DISTURBANCE 11 0.0007
710 ANHEDONIA 18 0.0007
711 SARS-COV-2 TEST POSITIVE 9 0.0007
712 COLD SWEAT 12 0.0007
713 SYNCOPE 68 0.0007
714 HEAD DISCOMFORT 12 0.0007
715 SOMNOLENCE 136 0.0007
716 ACCIDENT 8 0.0007
717 MUSCLE RIGIDITY 8 0.0007
718 SPEECH DISORDER 35 0.0007
719 DYSPHONIA 39 0.0007
720 CHOKING 13 0.0007
721 FREQUENT BOWEL MOVEMENTS 18 0.0007
722 SINUS CONGESTION 9 0.0007
723 DRY MOUTH 54 0.0007
724 HYPOPHAGIA 17 0.0007
725 GASTROENTERITIS VIRAL 12 0.0007
726 WHITE BLOOD CELL COUNT DECREASED 72 0.0007
727 DYSARTHRIA 25 0.0007
728 ASTHENIA 249 0.0007
729 DRUG RESISTANCE 17 0.0007
730 PRURITUS 254 0.0007
731 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
732 DEHYDRATION 88 0.0007
733 GINGIVAL BLEEDING 9 0.0007
734 BACK PAIN 153 0.0007
735 PALPITATIONS 77 0.0007
736 EYE PAIN 37 0.0007
737 PERIPHERAL COLDNESS 9 0.0007
738 SUICIDAL IDEATION 60 0.0007
739 HYPERSENSITIVITY 121 0.0007
740 RASH ERYTHEMATOUS 31 0.0006
741 MENTAL STATUS CHANGES 18 0.0006
742 TENDONITIS 10 0.0006
743 THERAPY NON-RESPONDER 29 0.0006
744 PSYCHOTIC DISORDER 19 0.0006
745 LETHARGY 37 0.0006
746 WEIGHT INCREASED 144 0.0006
747 PRODUCT PRESCRIBING ISSUE 14 0.0006
748 MIDDLE INSOMNIA 12 0.0006
749 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
750 INSOMNIA 170 0.0006
751 PARANOIA 11 0.0006
752 CHEST PAIN 118 0.0006
753 HEPATOCELLULAR INJURY 9 0.0006
754 WEIGHT DECREASED 177 0.0006
755 HAEMATEMESIS 16 0.0006
756 HEPATIC ENZYME INCREASED 43 0.0006
757 APHASIA 19 0.0006
758 GLAUCOMA 12 0.0006
759 THROMBOSIS 50 0.0006
760 NIGHT SWEATS 20 0.0006
761 RESPIRATORY ARREST 17 0.0006
762 GASTROINTESTINAL DISORDER 55 0.0006
763 PLATELET COUNT INCREASED 8 0.0006
764 NERVOUS SYSTEM DISORDER 19 0.0006
765 UNEVALUABLE EVENT 46 0.0006
766 MANIA 10 0.0006
767 NASOPHARYNGITIS 112 0.0006
768 PHOTOSENSITIVITY REACTION 10 0.0006
769 RECTAL HAEMORRHAGE 26 0.0006
770 NEOPLASM PROGRESSION 21 0.0006
771 FATIGUE 468 0.0006
772 FUNGAL INFECTION 20 0.0006
773 SWELLING FACE 39 0.0006
774 CYTOKINE RELEASE SYNDROME 12 0.0006
775 HYPOAESTHESIA ORAL 9 0.0006
776 INTENTIONAL SELF-INJURY 12 0.0006
777 ILLNESS 61 0.0006
778 BALANCE DISORDER 51 0.0006
779 DIARRHOEA 379 0.0006
780 DEEP VEIN THROMBOSIS 38 0.0006
781 LYMPHOMA 9 0.0006
782 INTENTIONAL PRODUCT USE ISSUE 51 0.0006
783 COLITIS 22 0.0006
784 FOOT FRACTURE 11 0.0006
785 RASH PAPULAR 13 0.0006
786 RASH GENERALISED 15 0.0006
787 PROTEINURIA 11 0.0006
788 ACUTE MYELOID LEUKAEMIA 9 0.0006
789 NAUSEA 453 0.0006
790 FALL 189 0.0006
791 TARDIVE DYSKINESIA 16 0.0006
792 DISEASE PROGRESSION 67 0.0006
793 MUSCLE TWITCHING 13 0.0006
794 BONE PAIN 33 0.0006
795 IRRITABLE BOWEL SYNDROME 12 0.0006
796 CONVULSION 32 0.0006
797 MOBILITY DECREASED 40 0.0006
798 INJURY 39 0.0006
799 THROAT TIGHTNESS 15 0.0006
800 RASH PRURITIC 30 0.0006
801 MYALGIA 94 0.0006
802 PRODUCT USE IN UNAPPROVED INDICATION 137 0.0006
803 TOOTHACHE 10 0.0006
804 ANXIETY 157 0.0006
805 DRUG INTOLERANCE 53 0.0005
806 DEPRESSED MOOD 29 0.0005
807 OCULAR HYPERAEMIA 26 0.0005
808 DISEASE RECURRENCE 26 0.0005
809 RASH 237 0.0005
810 DYSURIA 20 0.0005
811 BLOOD PRESSURE FLUCTUATION 13 0.0005
812 LIVER DISORDER 24 0.0005
813 LIP SWELLING 18 0.0005
814 HAEMORRHAGE INTRACRANIAL 8 0.0005
815 CONFUSIONAL STATE 86 0.0005
816 HEART RATE IRREGULAR 12 0.0005
817 EXPOSURE DURING PREGNANCY 33 0.0005
818 MEMORY IMPAIRMENT 72 0.0005
819 SKIN EXFOLIATION 44 0.0005
820 CHOLELITHIASIS 17 0.0005
821 MUSCULOSKELETAL CHEST PAIN 8 0.0005
822 RETCHING 11 0.0005
823 DRUG INEFFECTIVE 679 0.0005
824 THROAT IRRITATION 23 0.0005
825 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
826 DRUG ERUPTION 9 0.0005
827 CYSTITIS 16 0.0005
828 UPPER LIMB FRACTURE 10 0.0005
829 URTICARIA 84 0.0005
830 DIZZINESS 249 0.0005
831 MALIGNANT NEOPLASM PROGRESSION 51 0.0005
832 NERVOUSNESS 26 0.0005
833 BLOOD PRESSURE INCREASED 76 0.0005
834 PRODUCT ADMINISTRATION ERROR 10 0.0005
835 PRESYNCOPE 12 0.0005
836 MYOCARDIAL INFARCTION 86 0.0005
837 VERTIGO 30 0.0005
838 PANCREATITIS 26 0.0005
839 GLOSSODYNIA 11 0.0005
840 MALAISE 215 0.0005
841 PANCREATITIS ACUTE 11 0.0005
842 PERIPHERAL SWELLING 75 0.0005
843 RASH MACULAR 17 0.0005
844 ABDOMINAL PAIN UPPER 100 0.0005
845 CARDIAC FAILURE CONGESTIVE 39 0.0005
846 ABNORMAL BEHAVIOUR 19 0.0005
847 DEPRESSION 109 0.0005
848 OROPHARYNGEAL PAIN 44 0.0005
849 FLUID RETENTION 24 0.0005
850 HAEMATOCHEZIA 26 0.0005
851 PARAESTHESIA 74 0.0005
852 HAEMORRHAGE 49 0.0005
853 MOVEMENT DISORDER 15 0.0005
854 MUSCULOSKELETAL DISCOMFORT 8 0.0005
855 INFLUENZA LIKE ILLNESS 38 0.0005
856 FAECES DISCOLOURED 10 0.0005
857 HYPOAESTHESIA 69 0.0005
858 CARDIAC DISORDER 43 0.0005
859 KIDNEY INFECTION 9 0.0005
860 SKIN DISCOLOURATION 21 0.0005
861 OSTEONECROSIS 15 0.0005
862 FOETAL EXPOSURE DURING PREGNANCY 37 0.0005
863 RED BLOOD CELL COUNT DECREASED 13 0.0005
864 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
865 EMOTIONAL DISORDER 14 0.0005
866 HALLUCINATION 34 0.0005
867 SPINAL FRACTURE 9 0.0004
868 ISCHAEMIC STROKE 8 0.0004
869 HEADACHE 278 0.0004
870 NEUROPATHY PERIPHERAL 42 0.0004
871 BLOOD GLUCOSE DECREASED 21 0.0004
872 HOSPITALISATION 67 0.0004
873 POLLAKIURIA 18 0.0004
874 FEELING COLD 12 0.0004
875 MIGRAINE 41 0.0004
876 WOUND 12 0.0004
877 SWELLING 40 0.0004
878 PAIN 262 0.0004
879 CEREBROVASCULAR ACCIDENT 72 0.0004
880 FRACTURE 8 0.0004
881 TREATMENT FAILURE 35 0.0004
882 VISUAL ACUITY REDUCED 14 0.0004
883 ARTHRITIS 33 0.0004
884 GAIT DISTURBANCE 80 0.0004
885 DYSSTASIA 12 0.0004
886 COGNITIVE DISORDER 19 0.0004
887 ABDOMINAL DISCOMFORT 68 0.0004
888 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
889 MOOD ALTERED 11 0.0004
890 EXTRAPYRAMIDAL DISORDER 10 0.0004
891 FULL BLOOD COUNT DECREASED 8 0.0004
892 FEEDING DISORDER 8 0.0004
893 PAIN IN EXTREMITY 116 0.0004
894 DEATH 333 0.0004
895 VISION BLURRED 53 0.0004
896 DIPLOPIA 10 0.0004
897 DRY EYE 19 0.0004
898 ARTHRALGIA 158 0.0004
899 DISCOMFORT 23 0.0004
900 LABORATORY TEST ABNORMAL 11 0.0004
901 HEART RATE DECREASED 13 0.0004
902 PRURITUS GENERALISED 8 0.0004
903 LUNG NEOPLASM MALIGNANT 15 0.0004
904 DYSGEUSIA 27 0.0004
905 GAIT INABILITY 12 0.0004
906 PAIN IN JAW 10 0.0004
907 DRY SKIN 46 0.0003
908 DYSKINESIA 14 0.0003
909 MUSCLE SPASMS 63 0.0003
910 PRODUCT DOSE OMISSION ISSUE 100 0.0003
911 AGGRESSION 17 0.0003
912 VISUAL IMPAIRMENT 42 0.0003
913 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
914 MULTIPLE SCLEROSIS 16 0.0003
915 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
916 HOT FLUSH 25 0.0003
917 MUSCULOSKELETAL STIFFNESS 29 0.0003
918 PALLOR 9 0.0003
919 PRODUCT USE ISSUE 62 0.0003
920 TREATMENT NONCOMPLIANCE 18 0.0003
921 EYE PRURITUS 11 0.0003
922 NEPHROLITHIASIS 15 0.0003
923 TYPE 2 DIABETES MELLITUS 11 0.0003
924 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
925 HYPOACUSIS 14 0.0003
926 SURGERY 19 0.0003
927 ARTHROPATHY 18 0.0003
928 JOINT SWELLING 39 0.0003
929 EYE SWELLING 12 0.0003
930 INTESTINAL OBSTRUCTION 12 0.0003
931 IRRITABILITY 19 0.0003
932 HIP FRACTURE 10 0.0003
933 ROAD TRAFFIC ACCIDENT 13 0.0003
934 ALOPECIA 61 0.0003
935 WITHDRAWAL SYNDROME 13 0.0003
936 NECK PAIN 17 0.0003
937 EYE DISORDER 10 0.0003
938 CRYING 11 0.0003
939 ILL-DEFINED DISORDER 18 0.0003
940 EYE IRRITATION 17 0.0003
941 THERAPY INTERRUPTED 21 0.0003
942 FEELING HOT 18 0.0003
943 LIMB DISCOMFORT 9 0.0003
944 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
945 MUSCULOSKELETAL PAIN 15 0.0003
946 DEMENTIA 8 0.0003
947 NEOPLASM MALIGNANT 19 0.0003
948 DERMATITIS ATOPIC 15 0.0003
949 MOOD SWINGS 9 0.0003
950 EMOTIONAL DISTRESS 34 0.0003
951 ADVERSE DRUG REACTION 25 0.0003
952 INCORRECT DOSE ADMINISTERED 63 0.0003
953 FEELING ABNORMAL 64 0.0003
954 GASTRIC DISORDER 9 0.0003
955 NIGHTMARE 9 0.0003
956 BURNING SENSATION 18 0.0003
957 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
959 AMNESIA 16 0.0002
960 BLINDNESS 10 0.0002
961 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
962 THERAPEUTIC RESPONSE DECREASED 14 0.0002
963 DEVICE DISLOCATION 10 0.0002
964 COMPLETED SUICIDE 19 0.0002
965 SKIN BURNING SENSATION 16 0.0002
966 UNDERDOSE 16 0.0002
967 DRUG ABUSE 18 0.0002
968 BLOOD GLUCOSE INCREASED 40 0.0002
969 RHEUMATOID ARTHRITIS 23 0.0002
970 SKIN IRRITATION 9 0.0002
971 THERAPY CESSATION 9 0.0002
972 ADVERSE EVENT 16 0.0002
973 ACNE 12 0.0002
974 PRODUCT QUALITY ISSUE 20 0.0001
975 DEVICE MALFUNCTION 10 0.0001
976 PSORIASIS 18 0.0001
977 PRODUCT STORAGE ERROR 12 0.0001
978 INJECTION SITE ERYTHEMA 17 0.0001
979 PROSTATE CANCER 11 0.0001
980 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
982 INJECTION SITE BRUISING 10 0.0001
983 BREAST CANCER 11 0.0001
984 NO ADVERSE EVENT 21 0.0001
985 INJECTION SITE PAIN 35 0.0001
986 INJECTION SITE HAEMORRHAGE 9 0.0001
987 DRUG DEPENDENCE 17 0.0001
988 INJECTION SITE SWELLING 8 0.0001
989 DEVICE ISSUE 9 0.0001
990 DRUG WITHDRAWAL SYNDROME 8 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
992 DRUG DOSE OMISSION 9 0.0001